Anti human immunodeficiency virus-1 (HIV-1) agents 3. Synthesis and in vitro anti-HIV-1 activity of some N-arylsulfonylindoles

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 8, 2009, Pages 797-800

  Fan, Ling Ling ^a   Liu, Wu Qing ^b,c   Xu, Hui ^a   Yang, Liu Meng ^b   Lv, Min ^a   Zheng, Yong Tang ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Human immunodeficiency virus type 1; Inhibitor; N arylsulfonylindole

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INDOLE DERIVATIVE; N (3 NITROBENZENE)SULFONYL 6 METHYLINDOLE; N (3 NITROBENZENE)SULFONYLINDOLE; N SULFONYLINDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; CELL LINE; HIV-1; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 68149103322     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.797     Document Type: Article

References (27)

1. "2007 AIDS Epidemic Update," UNAIDS/WHO, Geneva, 2007.
2. Ho D. D., Bieniasz P. D., Cell, 133, 561-565 (2008).
3. Johston M. I., Hoth D. F., Science, 260, 1286-1293 (1993).
4. Lee J. S., Miyashiro H., Nakamura N., Hattori M., Chem. Pharm. Bull., 56, 711-714 (2008).
5. Struga M., Kossakowski J., Kedzierska E., Fidecka S., Stefanska J., Chem. Pharm. Bull., 55, 796-799 (2008).
6. Chiang C. C., Mouscadet J. F., Tsai H. J., Liu C. T., Hsu L. Y., Chem. Pharm. Bull., 55, 1740-1743 (2007).
7. Su C. X., Mouscadet J. F., Chiang C. C., Tsai H. J., Hsu L. Y., Chem. Pharm. Bull., 54, 682-686 (2006).
8. Ji L., Chen F. E., Feng X. Q., de Clercq E., Balzarini J., Pannecouque C., Chem. Pharm. Bull., 54, 1248-1253 (2006).
9. Tsai Y., Dukat M., Slassi A., MacLean N., Demchyshyn L., Savage J. E., Roth B. L., Hufesein S., Lee M., Glennon R. A., Bioorg. Med. Chem. Lett., 10, 2295-2299 (2000).
10. Russell M. G. N., Baker R. J., Barden L., Beer M. S., Bristow L., Broughton H. B., Knowles M., McAllister G., Patel S., Castro J. L., J. Med. Chem., 44, 3881-3895 (2001).
11. Pullagurla M., Siripurapu U., Kolanos R., Bondarev M. L., Dukat M., Setola V., Roth B. L., Glennon R. A., Bioorg. Med. Chem. Lett., 15, 5298-5302 (2005).
12. Xu H., Liu W. Q., Fan L. L., Chen Y., Yang L. M., Lv L., Zheng Y. T., Chem. Pharm. Bull., 56, 720-722 (2008).
13. Dai H. L., Liu W. Q., Xu H., Yang L. M., Lv M., Zheng Y. T., Chem. Pharm. Bull., 57, 84-86 (2009).
14. Xu H., Desrivot J., Bories C., Loiseau P. M., Franck X., Hocquemiller R., Figadere B., Bioorg. Med. Chem. Lett., 16, 815-820 (2006).
15. Xu H., Jian K. Z., Guan Q., Ye F., Lv M., Chem. Pharm. Bull., 55, 1755-1757 (2007).
16. Xu H., Fan L. L., Chem. Pharm. Bull., 57, 321-323 (2009).
17. Xu H., Zhang L., Su, B. F., Zhang X., Tian X., Heterocycles, 77, 293-300 (2009).
18. Xu H., Zhang X., Tian X., Lu M., Wang Y. G., Chem. Pharm. Bull., 50, 399-402 (2002).
19. Okuma K., Yasuda T., Takeshita I., Shioji K., Yokomori Y., Tetrahedron, 63, 8250-8254 (2007).
20. Muratake H., Natsume M., Heterocycles, 29, 783-794 (1989).
21. Abid M., Teixeira L., Torok B., Tetrahedron Lett., 48, 4047-4050 (2007).
22. Ramakrishna V. S. N., Shirsath V. S., Kambhampati R. S., Vishwakarma S., Kandikere N. V., Kota S., Jasti V., WO 2007/020652 A1.
23. Arisawa M., Terada Y., Takahashi K., Nakayawa M., Nishida A., J. Org. Chem., 71, 4255-4261 (2006).
24. Bergman J., Pelcman B., Tetrahedron, 44, 5215-5228 (1988).
25. Zhang G. H., Wang Q., Chen J. J., Zhang X. M., Tam S. C., Zheng Y. T., Biochem. Biophys. Res. Commun., 334, 812-816 (2005).
26. Zheng Y. T., Zhang W. F., Ben K. L., Wang J. H., Immunopharmacol. Immunotoxicol., 17, 69-79 (1995).
27. Wang Q., Ding Z. H., Liu J. K., Zheng Y. T., Antiviral Res., 64,189-194 (2004).